ANNETTE HOOD: Open Payments
NPI 1174611537 · FLORISSANT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,422 in 47 payments from 18 companies in 2025. Trend: 2023 $249 · 2024 $1,405 · 2025 $2,422
Food & beverage: $1,514Consulting: $908
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $919 |
| Travere Therapeutics, Inc. | 5 | $232 |
| AstraZeneca Pharmaceuticals LP | 6 | $210 |
| Novartis Pharmaceuticals Corporation | 3 | $179 |
| Vifor Pharma, Inc. | 4 | $173 |
| Calliditas Therapeutics US Inc. | 2 | $130 |
| Otsuka America Pharmaceutical, Inc. | 4 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $76 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Fresenius USA Marketing, Inc. | 3 | $60 |
Products named: Rivfloza, Vanrafia, Veltassa, LOKELMA, TARPEYO, Filspari, JYNARQUE, JARDIANCE.
Industry payments across MO — which companies pay providers there.
